comparemela.com
6
7
8
9
10
11
12
Latest Breaking News On - Colin bristow - Page 5 : comparemela.com
PFIZER INC : UBS remains Neutral -October 18, 2023 at 07:53 am EDT
In his latest research note, analyst Colin Bristow confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price remains set at USD 36.
Colin-bristow
Markets
PFIZER INC : UBS sticks Neutral -October 16, 2023 at 03:28 pm EDT
In a research note published by Colin Bristow, UBS gives a Neutral rating to the stock. The target price continues to be set at USD 36.
Colin-bristow
Markets
Covid Hospitalizations Jump. So Could Vaccine Demand.
Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing. And investors are turning bullish.
Montana
United-states
Wuhan
Hubei
China
Rhode-island
Americans
Scott-gottlieb
Colin-bristow
Jared-holz
Spencer-platt-getty
Hartaj-singh
Covid-19 Hospitalizations Jump. So Could Vaccine Demand.
Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing. And investors are turning bullish.
Montana
United-states
Rhode-island
Wuhan
Hubei
China
Americans
Colin-bristow
Spencer-platt-getty
Scott-gottlieb
Jared-holz
Josh-nathan-kazis
UBS says this stock is the 'best story' among U.S. large caps, sees more than 16% upside
UBS expects a steady stream of positive news to propel this large-cap stock higher as its revenue growth accelerates.
Lilly-mounjaro
Eli-lilly
Drug-administration
Novo-nordisk
European-union
Colin-bristow
Wall-street
Biotech-and-pharmaceuticals
Health-care-industry
Novo-nordiska-s
Eli-lilly-and-co
Investment-strategy
vimarsana © 2020. All Rights Reserved.